pCPAO
pan-Canadian Pharmaceutical Alliance (pCPA): November 2019 Trends and Insights The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the November 30, 2019 status of brand negotiations. Highlights since the last update include: 6 products completed CADTH review, for a total of 9 files under consideration; 4 products initiated pCPA negotiations, for a total of 34 active negotiations; 12 negotiations completed for a total of 294 completed negotiations; No negotiations closed, for…
pan-Canadian Pharmaceutical Alliance (pCPA): October 2019 Trends and Insights The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the October 31, 2019 status of brand negotiations. Highlights since the last update include: 4 products completed CADTH review, for a total of 7 files under consideration; 2 products initiated pCPA negotiations, for a total of 42 active negotiations; 6 negotiations completed for a total of 282 completed negotiations; 2 negotiation closed, for…
pan-Canadian Pharmaceutical Alliance (pCPA): September 2019 Trends and Insights The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the September 30, 2019 status of brand negotiations. Highlights since the last update include: 4 products completed CADTH review, for a total of 6 files under consideration; 8 products initiated pCPA negotiations, for a total of 48 active negotiations; 6 negotiations completed for a total of 276 completed negotiations; 1 negotiation closed, for…
Toronto, September 18, 2019 – MORSE Consulting is pleased to launch the Canadian Reimbursement Trends and Timelines report – a comprehensive, credible and relevant source of market access intelligence. The market access pathway in Canada is going through an unprecedented level of change and uncertainty. This 58-page PowerPoint report is aimed at not only helping market access professionals plan for future launches but can be a valuable education tool for…
pan-Canadian Pharmaceutical Alliance (pCPA): August 2019 Trends and Insights The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the August 31, 2019 status of brand negotiations. Highlights since the last update include: 5 products completed CADTH review, for a total of 13 files under consideration; 8 products initiated pCPA negotiations, for a total of 47 active negotiations; 7 negotiations completed for a total of 270 completed negotiations; 1 negotiation closed, for…
pan-Canadian Pharmaceutical Alliance (pCPA): July 2019 Trends and Insights The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the status of brand negotiations as of July 31, 2019. Highlights since the last update include: 5 products completed CADTH review, for a total of 12 files under consideration; 7 products initiated pCPA negotiations, for a total of 47 active negotiations; 6 negotiations completed for a total of 263 completed negotiations; 3 negotiations…
pan-Canadian Pharmaceutical Alliance (pCPA): June 2019 Trends and Insights The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the status of brand negotiations as of June 30, 2019. Highlights since the last update include: 6 products completed CADTH review, for a total of 15 files under consideration; 9 products initiated pCPA negotiations, for a total of 49 active negotiations; 4 negotiations completed for a total of 257 completed negotiations; 3 negotiations…
pan-Canadian Pharmaceutical Alliance (pCPA): May 2019 Trends and Insights The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the status of brand negotiations as of May 31, 2019. Highlights since the last update include: 2 negotiations completed for a total of 253 completed negotiations; 2 negotiations closed, for a total of 37 closed negotiations; 1 file closed without negotiations, for a total of 65 declined negotiations; 10 products completed CADTH review,…
pan-Canadian Pharmaceutical Alliance (pCPA): April 2019 Negotiation Status Update The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the status of brand negotiations as of April 30, 2019. Highlights since the last update include: 4 negotiations completed for a total of 251 completed negotiations No negotiations closed, for a total of 35 closed negotiations 1 file closed without negotiations, for a total of 64 declined negotiations 4 products completed CADTH review,…
pan-Canadian Pharmaceutical Alliance (pCPA): March 2019 Negotiation Status Update The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the status of brand negotiations as of March 31, 2019. Highlights since the last update include: 5 negotiations completed for a total of 247 completed negotiations 2 negotiations closed, for a total of 35 closed negotiations No new files closed without negotiations, for a total of 63 declined negotiations 8 products completed CADTH…
pan-Canadian Pharmaceutical Alliance (pCPA): February 2019 Negotiation Status Update The pan-Canadian Pharmaceutical Alliance Office (pCPAO) has issued the status of brand negotiations as of February 28, 2019. The key highlights since the last update are: 8 negotiations were completed for a total of 242 completed negotiations No negotiations were closed, for a total of 33 closed negotiations The pCPA decided to decline negotiations on 1 file, for a total…
MORSE Consulting is pleased to release its 2018 pCPA Year in Review infographic. The purpose of this resource is to help market access professionals provide a top-line pCPA performance summary to both internal and external stakeholders. This infographic compares the negotiation activities of the pCPA in 2018 to 2017 as it relates to: completed negotiations by source (CDR, pCODR, pCPA initiated); a breakdown of pCPA initiated files; and completed negotiation…
pan-Canadian Pharmaceutical Alliance (pCPA): January 2019 Negotiation Status Update The pan-Canadian Pharmaceutical Alliance Office (pCPAO) has issued the status of brand negotiations as of January 31, 2019. The key highlights since the last update are: 3 negotiations were completed for a total of 234 completed negotiations 3 negotiations were closed, for a total of 33 closed negotiations The pCPA decided to decline negotiations on 2 files, for a total…
pan-Canadian Pharmaceutical Alliance (pCPA): December 2018 Negotiation Status Update The pan-Canadian Pharmaceutical Alliance Office (pCPAO) issued the status of brand negotiations as of December 31, 2018. The key highlights since the November update are: 5 products received a final HTA recommendation, for a total of 13 files under consideration 2 products initiated pCPA negotiations, for a total of 46 active negotiations 7 negotiations were completed for a total of…
pan-Canadian Pharmaceutical Alliance (pCPA): November 2018 Negotiation Status Update The pan-Canadian Pharmaceutical Alliance Office (pCPAO) has issued the status of brand negotiations as of November 30, 2018. The key highlights since the October update are: 7 new drug products have initiated pCPA negotiations, for a total of 51 active negotiations; 9 negotiations were completed for a total of 225 completed negotiations; and 2 negotiations were closed since the last…
Contact Us
MORSE Consulting Inc.
MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.
© 2023 MORSE Consulting Inc. All rights reserved. |
Site by Directica Media
pCPAO - Info and details on - Page 4 of 6 - MORSE Consulting Inc.
